These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 19118524

  • 21. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
    Campana G, Pasini P, Roda A, Spampinato S.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1755-63. PubMed ID: 15935148
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Expression and activation of the farnesoid X receptor in the vasculature.
    Bishop-Bailey D, Walsh DT, Warner TD.
    Proc Natl Acad Sci U S A; 2004 Mar 09; 101(10):3668-73. PubMed ID: 14990788
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries.
    Nicolaou KC, Evans RM, Roecker AJ, Hughes R, Downes M, Pfefferkorn JA.
    Org Biomol Chem; 2003 Mar 21; 1(6):908-20. PubMed ID: 12929628
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. 5Alpha-bile alcohols function as farnesoid X receptor antagonists.
    Nishimaki-Mogami T, Kawahara Y, Tamehiro N, Yoshida T, Inoue K, Ohno Y, Nagao T, Une M.
    Biochem Biophys Res Commun; 2006 Jan 06; 339(1):386-91. PubMed ID: 16300737
    [Abstract] [Full Text] [Related]

  • 29. Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray.
    Higashiyama H, Kinoshita M, Asano S.
    Acta Histochem; 2008 Jan 06; 110(1):86-93. PubMed ID: 17963822
    [Abstract] [Full Text] [Related]

  • 30. FXR: a metabolic regulator and cell protector.
    Wang YD, Chen WD, Moore DD, Huang W.
    Cell Res; 2008 Nov 06; 18(11):1087-95. PubMed ID: 18825165
    [Abstract] [Full Text] [Related]

  • 31. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.
    Szalai AJ, van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, Volanakis JE.
    J Immunol; 1998 Jun 01; 160(11):5294-9. PubMed ID: 9605127
    [Abstract] [Full Text] [Related]

  • 32. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR).
    Flatt B, Martin R, Wang TL, Mahaney P, Murphy B, Gu XH, Foster P, Li J, Pircher P, Petrowski M, Schulman I, Westin S, Wrobel J, Yan G, Bischoff E, Daige C, Mohan R.
    J Med Chem; 2009 Feb 26; 52(4):904-7. PubMed ID: 19159286
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of coumestrol on lipid and glucose metabolism as a farnesoid X receptor ligand.
    Takahashi M, Kanayama T, Yashiro T, Kondo H, Murase T, Hase T, Tokimitsu I, Nishikawa J, Sato R.
    Biochem Biophys Res Commun; 2008 Aug 01; 372(3):395-9. PubMed ID: 18457666
    [Abstract] [Full Text] [Related]

  • 35. A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
    Shih DM, Kast-Woelbern HR, Wong J, Xia YR, Edwards PA, Lusis AJ.
    J Lipid Res; 2006 Feb 01; 47(2):384-92. PubMed ID: 16269825
    [Abstract] [Full Text] [Related]

  • 36. New targets in and potential treatments for cholesterol gallstone disease.
    Doggrell SA.
    Curr Opin Investig Drugs; 2006 Apr 01; 7(4):344-8. PubMed ID: 16625821
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.
    Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V, André P.
    J Hepatol; 2008 Feb 01; 48(2):192-9. PubMed ID: 18096266
    [Abstract] [Full Text] [Related]

  • 38. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.
    Maran RR, Thomas A, Roth M, Sheng Z, Esterly N, Pinson D, Gao X, Zhang Y, Ganapathy V, Gonzalez FJ, Guo GL.
    J Pharmacol Exp Ther; 2009 Feb 01; 328(2):469-77. PubMed ID: 18981289
    [Abstract] [Full Text] [Related]

  • 39. Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation.
    Hu T, Chouinard M, Cox AL, Sipes P, Marcelo M, Ficorilli J, Li S, Gao H, Ryan TP, Michael MD, Michael LF.
    J Biol Chem; 2006 Dec 29; 281(52):39831-8. PubMed ID: 17065154
    [Abstract] [Full Text] [Related]

  • 40. Farnesoid X receptor agonists in biliary tract disease.
    Fiorucci S, Baldelli F.
    Curr Opin Gastroenterol; 2009 May 29; 25(3):252-9. PubMed ID: 19300246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.